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Background: The aim was to describe the management of benign gallbladder disease and 
identify characteristics associated with all-cause 30-day readmissions and complications in a   
prospective population-based cohort  
Methods: Data were collected on consecutive patients undergoing cholecystectomy in acute 
UK and Irish hospitals between 1 March and 1 May 2014. Potential explanatory variables 
influencing all cause 30-day readmissions and complications were analysed by means of 
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multilevel, multivariable logistic regression modelling using a two-level hierarchical structure 
with patients (level 1) nested within hospitals (level 2). 
Results: Data were collected on 8909 patients undergoing cholecystectomy from 167 
hospitals. Some 1451 cholecystectomies (16.3 per cent) were performed as an emergency, 
4165 (46.8 per cent) as elective operations, and 3293 patients (37.0 per cent) had at least one 
previous emergency admission, but were operated on a delayed basis. The readmission and 
complication rates at 30 days were 7.1 per cent (633 of 8909) and 10.8 per cent (962 of 8909) 
respectively. Both readmissions and complications were independently associated with 
increasing ASA fitness grade, duration of surgery, and increasing numbers of emergency 
admissions with gallbladder disease before cholecystectomy. No identifiable hospital 
characteristics were linked to readmissions and complications.  
Conclusion: Readmissions and complications following cholecystectomy are common and 
associated with patient and disease characteristics. 
 
+A: Introduction 
Benign gallbladder disease is a major global health burden1. It is estimated that for every 
100 000 of the world’s population, 115 patients undergo cholecystectomy every year. In 
England alone, approximately 70 000 cholecystectomies are performed annually2. Among 
those fit for surgery, patients follow one of three pathways from presentation to definitive 
treatment linked to emergency admissions with gallbladder disease: emergency 
cholecystectomy during an emergency admission; elective cholecystectomy with no previous 
emergency admission; or delayed cholecystectomy following one or more previous 
emergency admissions with gallbladder pathology. 
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Variations in outcomes exist following these different patient pathways. When 
performed with no previous emergency admission, either as an index emergency or elective 
operation, cholecystectomy is associated with fewer gallbladder-specific complications, a 
shorter total length of hospital stay and similar operative complications compared with those 
among patients who have had one or more emergency admissions3–5. Many of these studies 
were conducted in specialized centres by enthusiasts. In contrast, population-level data from 
Hospital Episodes Statistics (HES)2 and a retrospective study from Scotland6 both suggested 
that emergency cholecystectomy may be associated with poorer surgical outcomes. The 
reasons for these differences are unclear, but may be due to patient, disease, surgical and 
hospital variables not fully realized in administrative data sets. 
Patient outcomes are used to measure quality of healthcare, such as readmission, 
complication, reoperation and mortality rates6–13. The mortality rate is low following 
cholecystectomy, and therefore a poor measure of quality in this cohort14. In contrast, 
reducing hospital readmissions and complications after surgery can lower hospital costs and 
improve patient satisfaction15–17. The causes of readmission and complications after 
cholecystectomy have been poorly studied in large prospective series, but may vary 
according to patient pathways11. 
Over the past 8 years, trainee-led networks in the UK have adopted a collaborative 
approach to deliver prospective population-level data collection, and measure patient, 
disease, surgical and hospital variables with short-term endpoints such as readmissions and 
complications18. Using these networks, a prospective, population-based cohort study was 
conducted to describe management of patients with benign gallbladder disease19, and identify 
patient, disease, surgical and hospital-related characteristics that might be associated with all-
cause 30-day readmission and complications.   
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+A: Methods 
The study was carried out as described previously19. The study protocol did not require 
research registration as anonymized, observational data were collected. This was confirmed 
by the online National Research Ethics Service decision tool (http://www.hra-
decisiontools.org.uk/research/), and further supported by written confirmation and advice 
from the Research and Development Director at University Hospitals Birmingham NHS 
Foundation Trust, UK.  The study was registered as a clinical audit or service evaluation at 
each participating hospital under the supervision of a named senior investigator (consultant 
surgeon). 
+B: Inclusion and exclusion criteria 
All patients undergoing cholecystectomy for benign gallbladder diseases in acute UK and 
Irish hospitals participating in this study between 1 March and 1 May 2014 were included. 
Patients were grouped according to the timing of cholecystectomy: emergency 
cholecystectomy, defined as cholecystectomy during an emergency admission;  delayed 
cholecystectomy, defined as a scheduled cholecystectomy following an emergency admission 
with gallbladder disease in the preceding 12 months; or elective cholecystectomy, defined as 
a planned elective admission for cholecystectomy following referral by a family doctor and 
addition to the routine surgical waiting list from an outpatient department visit. Open, 
laparoscopic and laparoscopic procedures converted to open surgery were included. 
Cholecystectomies for a known gallbladder cancer or as a part of another surgical procedure. 
(such as pancreaticoduodenectomy) were excluded.   
+B: Outcome measures 
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Planned analyses comprised a description of current management of benign gallbladder 
disease with readmission and complication rates. Variations in 30-day complication and 
readmission rates were studied as well as predictive factors for these events. A list of 
recorded complications with their definitions is available in Table S1 (supporting 
information).  
+B: Data quality 
To standardize data quality, a quality assurance programme was developed19. This included a 
detailed study protocol, pilot phase, and a requirement for a minimum of 95 per cent data 
completeness at submission. Case ascertainment, including readmission to a different hospital 
from where cholecystectomy was performed, and data accuracy, were validated by 
independent investigators at selected hospitals, who checked data from 10 per cent of patients 
against original medical records. These independent investigators were not involved in the 
original data collection. 
+B: Explanatory variables 
Patient, disease and hospital characteristics were considered as potential explanatory 
variables influencing the performance of emergency cholecystectomy. A full list including 
definitions has been published previously19. Briefly, patient characteristics included: age, sex, 
ASA fitness grade (I, normal healthy patient; II, mild systemic disease; III, severe systemic 
disease; IV, severe systemic disease that is a constant threat to life; V, moribund patient who 
is not expected to survive without the operation) and BMI (less than 17.9 kg/m2, 
underweight; 18.0–24.9 kg/m2, normal; 25.0–29.9 kg/m2, overweight; 30.0–34.9 kg/m2, 
moderate obesity; 35.0 kg/m2 and above, severe or very severe obesity). The following 
disease characteristics were considered: indication (biliary colic, cholecystitis, pancreatitis, 
common bile duct (CBD) stones), ultrasound findings (gallbladder wall thickness, dilated 
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CBD), findings from other radiological investigations (CT, magnetic retrograde 
cholangiopancreatography (MRCP), endoscopic retrograde cholangiopancreatography 
(ERCP)) and total number of emergency admissions with biliary symptoms in the 12 months 
before cholecystectomy.  
Surgical characteristics included degree of difficulty according to the Nassar score20 
and surgical approach (laparoscopic, open or laparoscopic converted to open surgery). 
Hospital characteristics, including type (university or not), specialist hepatobiliary centre and 
acute hospital status, were recorded along with the number of consultants within the reporting 
hospital performing cholecystectomy, hospital country, number of beds within the reporting 
hospital (less than 100, 101–500, 501–1000, more than 1000) and presence of an on-site 
ERCP service. The hospital’s policy regarding the ease of performing intraoperative 
cholangiography and use of dedicated emergency gallbladder operating lists were considered. 
The consultant’s presence, specialty and grade were also recorded at the time of 
cholecystectomy. 
+B: Statistical analysis 
Results are reported in accordance with the STROBE statement for observational studies21. 
Crude rates of emergency cholecystectomy at each hospital were calculated for all patients. 
Descriptive statistics were obtained for all variables. Median values with interquartile range 
(i.q.r.) are reported. The 2 test or Fisher’s exact test, as appropriate, was used to identify 
differences between categorical variables.  
To investigate the relationship between 30-day readmission and complication rates 
and the variables studied, data were analysed using multilevel, multivariable logistic 
regression modelling.  Both 30-day readmission and complication rates were recorded as 
binary outcome measures, requiring a logistic analytical approach. These data comprise a 
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two-level hierarchical structure, with patients at level 1, nested within hospitals at level 2. 
Multilevel (hierarchical) modelling was selected owing to the structure of the data. Patient 
outcomes are not independent of each other as patients are clustered within hospitals. This 
clustering introduces multilevel dependency or correlation among patient observations that 
can have implications for model parameter estimates. Because of this dependency among 
observations, multilevel modelling has advantages over other approaches, such as logistic 
regression analysis, which assume that observations are independent.  
Before model building, variables were investigated for potential confounding 
relationships using correlation and scatter plots. As the variables included in this study could 
be viewed as being on a causal path potentially linking each variable to the outcome, they 
were assessed during model building and none were excluded. Variable collinearity was also 
tested using variance inflation factor scores.  
Variables were included in the models if they were found to be significant at the 5 per 
cent level. The forward and back Collett method22 was used to select variables for inclusion.  
To investigate between-hospital variation, the random intercept model was extended 
to a random coefficient model, including each variable in turn, allowing the factor to vary 
across hospitals. Results are expressed as adjusted odds ratios (ORs) with 95 per cent 
confidence intervals (c.i.). 
All two-way interactions were assessed and no significant interactions were identified 
in the final models. Model testing was performed using likelihood ratio tests, Wald tests, and 
residual and deviance plots. Owing to the binary nature of the outcome data, the multilevel 
logistic regression model deviates from the normal assumptions that underlie regression 
models and as such these were not tested for. However, testing for the assumption of 
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independent co-variance structure between random effects was not possible as no explanatory 
variables were included at level 2. 
Missing data accounted for 0.8 per cent of the data set. Models were fitted with 
missed data and therefore all available data were included. 
All statistical analyses were performed using Stata® version 12 (StataCorp, College 
Station, Texas, USA). The multilevel, multivariable logistic regression modelling was carried 
out in MLwiN version 2.14 (http://www.cmm.bristol.ac.uk/MLwiN).  
+A: Results 
Data were collected on 8909 patients undergoing cholecystectomy from 167 hospitals. Case 
ascertainment and accuracy of collected data was above 95.3 and 99.2 per cent respectively, 
compared with information from 10 per cent of patients checked independently against the 
original medical records.  
The median age of the cohort was 51 (38–64) years. The numbers of patients 
undergoing emergency, delayed and elective cholecystectomy were 1451 (16.3 per cent), 
3293 (37.0 per cent) and 4165 (46.8 per cent) respectively. A total of 3713 patients (41.7 per 
cent) had at least one emergency admission with acute gallbladder disease before 
cholecystectomy. Elective cholecystectomy was mainly undertaken for biliary colic, in 
younger women with a low ASA fitness grade, who did not require additional radiological 
tests or interventions (such as MRCP or ERCP) compared with patients who had delayed and 
emergency cholecystectomy (Table 1). Patients with biliary colic underwent elective surgery 
(73.3 per cent) more frequently, whereas cholecystitis and pancreatitis were more frequently 
treated by delayed cholecystectomy (53.0 and 64.0 per cent respectively). Elective 
cholecystectomy was more likely to be completed laparoscopically, was less difficult as 
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assessed by the operating surgeon, and with fewer intraoperative complications (bile 
contamination, stones spilled, bleeding, bowel and significant biliary injury), compared with 
delayed and emergency cholecystectomy (Table 2). The difference in incidence of bile duct 
injury, however, did not reach statistical significance. The median duration of an elective 
procedure was 60 (45–79) min compared with 65 (50–90) and 80 (60–110) min for delayed 
and emergency cholecystectomy respectively.  
+B: Outcomes at 30 days  
Readmission and complication rates at 30 days were 7.1 per cent (633 of 8909) and 10.8 per 
cent (962 of 8909) respectively (Table 3). The rates of readmission, overall complications 
and individual complications at 30 days were higher in the delayed and emergency groups 
than in the elective group. Both readmission and complication rates differed according to the 
number of surgical admissions (Fig. 1). Readmission rates among patients with no, one or at 
least two surgical admissions before cholecystectomy were 6.1, 7.2 and 12.9 per cent 
respectively; corresponding complication rates were 8.9, 11.8 and 19.1 per cent.  
Reoperations were more frequent following delayed cholecystectomy, although this 
difference was not statistically significant. The 30-day mortality rate was higher when 
cholecystectomy was performed as an emergency or delayed operation, but again this 
difference was not statistically significant.  
+C: Thirty-day readmission rate 
The null random intercept model containing no exploratory variables was used to test 
variation across the 167 hospitals, and demonstrated a statistically significant between-
hospital variance (likelihood ratio statistic 11.57, P = 0.003). Estimates of the hospital effects 
obtained from the null model showed the hospital effects in rank order together with 95 per 
cent confidence intervals (Fig. 2). Only two of 167 hospitals (1.2 per cent) had 30-day 
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readmission rates higher than the rest. When the model was extended to include explanatory 
variables, duration of surgery and greater number of surgical admissions before the index 
surgery were associated with a higher risk of readmission, whereas there was no difference in 
readmissions between emergency and delayed operation (Table 4). Elective cholecystectomy, 
younger patients and ASA score I–II were associated with a lower risk of readmission.  The 
variables included in this multilevel model accounted for 97 per cent of the detected 
variation.  BMI, indication for cholecystectomy and hospital-related variables were not 
independently associated with readmission. 
+C: Thirty-day complication rate 
The null random intercept model demonstrated significant between-hospital variance 
(likelihood ratio statistic 74.80, P = 0.003). Eleven hospitals (6.6 per cent) had a significantly 
different 30-day complication rate from the others (Fig. 3). When the model was extended to 
include explanatory variables, age, ASA grade, surgical admission type, number of 
admissions and duration of surgery were again associated with complications (Table 5). In 
addition, having an open or a laparoscopic procedure converted to open surgery and a greater 
degree of operative difficulty were associated with a higher risk of complications. These 
variables accounted for 93 per cent of the detected variation.  Other patient categories, 
disease and hospital factors were not independently associated with the outcomes measured. 
+A: Discussion 
This study evaluated the current management and outcomes of cholecystectomy for benign 
gallbladder disease in the UK and Ireland. Readmissions and complications were common 
and varied across the 167 hospitals studied.  An emergency or delayed operation and greater 
numbers of surgical admissions before the index surgery were associated with a higher risk of 
readmission and complications. Intraoperative features, such as difficulty, duration and 
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operative method, were also associated with poorer outcomes across hospitals. Importantly, 
the hospital characteristics analysed did not influence these associations.  
Readmission and complication rates at 30 days were similar to those reported 
previously. Other studies2,6,12,23–26 have described patient and hospital factors, both 
independently and in combination, linked to complications and readmissions. Factors 
associated with readmission or complication in the present study were analysed by means of 
hierarchical modelling. The advantage of this type of analysis was that it allowed the effects 
of patient variables on certain outcomes to be considered independently of hospital variables 
that may also influence outcomes27. Age, ASA grade, duration of surgery, operative approach 
and degree of operative difficulty were all associated with worse outcomes. as demonstrated 
previously25,28.  
Increasing numbers of emergency admissions before cholecystectomy were 
independently associated with both readmission and complication rates here. This supports a 
pathway in which definitive cholecystectomy should be performed during the first admission. 
Emergency cholecystectomy was mainly carried out in younger patients and those presenting 
with cholecystitis, whereas older patients and those requiring further investigations tended to 
be discharged and brought back for a delayed cholecystectomy.  
Delayed cholecystectomy can result in emergency readmissions and poorer 
outcomes29–33. Logistical barriers to emergency cholecystectomy, such as lack of prompt 
access to specialist investigations and emergency theatre availability, appear to explain 
differences in service provision. Hospital policy and surgeon or patient preference may 
contribute to delaying cholecystectomy. Increasing the numbers of emergency 
cholecystectomies by addressing modifiable barriers, such as reducing the number of surgical 
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admissions with gallbladder pathology before cholecystectomy, would improve outcomes. 
This is generalizable to healthcare providers outside the UK and Ireland. 
In contrast to previous studies, there was no statistical difference in readmissions and 
complications when emergency and delayed cholecystectomies were compared, suggesting 
that the delayed cohort was not homogeneous. Definitions of emergency and delayed 
cholecystectomy varied in previous studies. Some considered emergency or early 
cholecystectomy to comprise operations performed within 48–72 h of symptom onset5. A 
population-based study4 of 14 200 patients in Canada showed that patients experienced fewer 
complications when cholecystectomy was performed within 7 days of hospital admission. A 
study3 in Switzerland demonstrated that a 6-day delay in performing emergency 
cholecystectomy was associated with a higher conversion rate (12 per cent at day 0 versus 18 
per cent at day 6), more complications (5.7 versus 13 per cent respectively) and the 
reoperation rate almost double in the delayed compared with the emergency group (0.8 versus 
0.5 per cent).  
There are limitations to the present study. The data represent a 2-month snapshot of 
practice and this may account for unexpected observations, such as the inverse association 
between age and risk of readmission. However, short intensive data collection allowed 
surgical teams to contribute meaningful numbers of patients with high levels of accuracy and 
without additional resources. The number of patients who did not undergo cholecystectomy is 
unknown. It seems intuitive that those with less co-morbidity are more likely to be offered 
cholecystectomy. The overall models accounted for nearly 90 per cent of the variations in 
outcomes seen across the hospitals studied, suggesting the presence of other factors not 
characterized in this study.  Despite these limitations, the accuracy of the data set was 
validated independently and it contained variables not typically collected in similar studies.  
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 Sweden34, Denmark35 and Switzerland25 use prospective registries of 
cholecystectomy for continual quality improvement. Although this is costly and time-
consuming, the results of this prospective population-based cohort study demonstrate that 
cholecystectomy following multiple surgical admissions is linked to 30-day complications 
and readmissions. Measuring numbers of surgical admissions before cholecystectomy 
provides a simple quality improvement metric. There needs to be a focus on offering 
emergency rather than delayed cholecystectomy for patients presenting with acute benign 
gallbladder disease.  
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Fig. 1 Thirty-day a readmission rate and b complication rate according to number of 
emergency admissions before cholecystectomy   
Fig. 2 Plot examining hospital effects (residuals) and corresponding 95 per cent confidence 
intervals for 30-day readmissions 
 Fig. 3 Plot examining hospital effects (residuals) and corresponding 95 per cent confidence 
intervals for 30-day complications 
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Table 1 Patient and disease characteristics, and radiological investigations according to 
performance of emergency, delayed or elective cholecystectomy 
 
All patients 
(n = 8909) 
Emergency 
cholecystectomy 
(n = 1451) 
Delayed 
cholecystectomy 
(n = 3293) 
Elective 
cholecystectomy 
(n = 4165) P* 
Age (years)     < 0.001 
< 40 2534 (28.4) 441 (30.4) 859 (26.1)  1234 (29.6)  
40–60 3531 (39.6) 510 (35.1) 1161 (35.3)  1860 (44.7) 
61–80 2602 (29.2) 435 (30.0)  1108 (33.6) 1059 (25.4) 
> 80 242 (2.7) 65 (4.5) 165 (5.0) 12 (0.3) 
Sex     < 0.001 
F 6565 (73.7) 1000 (68.9) 2189 (66.5) 3.376 (81.1)  
M 2344 (26.3) 451 (31.1) 1104 (33.5) 789 (18.9) 
BMI (kg/m2)     0.033 
< 17.9 41 (0.5) 6 (0.4) 17 (0.5) 18 (0.5)  
18.0–24.9 1749 (20.6) 262 (19.4) 667 (21.1) 820 (20.5) 
25.0–29.9 3101 (35.7) 494 (36.6) 1108 (35.1) 1429 (35.8) 
30.0–34.9 2078 (24.4) 337 (25.0) 805 (25.5) 936 (23.4) 
≥ 35.0 1600 (18.8) 250 (18.5) 560 (17.7) 790 (19.8) 
Unknown 410 102 136 172  
ASA fitness grade     < 0.001 
I–II 7897 (89.4) 1220 (85.0) 2873 (87.9) 3804 (92.1)  
> III 937 (10.6) 216 (15.0) 396 (12.1) 325 (7.9) 
   Unknown 75 15 24 36  
Indication     < 0.001 
Colic 4683 (52.6) 295 (20.3) 955 (29.0) 3433 (82.5)  
Cholecystitis 2581 (29.0) 795 (54.8) 1369 (41.6) 417 (10.0) 
Pancreatitis 851 (9.6) 268 (18.5) 545 (16.6) 38 (0.9) 
CBD stone 589 (6.6) 83 (5.7) 386 (11.7) 120 (2.9) 
Polyp 135 (1.5) 2 (0.1) 16 (0.5) 117 (2.8) 
Dyskinesia 31 (0.3) 1 (0.1) 9 (0.3) 21 (0.5) 
Acalculous 28 (0.3) 6 (0.4) 11 (0.3) 11 (0.3) 
Other 2 (0.0) 0 (0) 0 (0) 2 (0.0) 
   Missing 9 1 2 6  
No. of admissions 
before surgery 
    < 0.001 
0 5196 (58.3) 913 (62.9) 118 (3.6) 4165 (100.0)  
1 2859 (32.1) 361 (24.9) 2498 (75.9) 0 (0.0) 
2 623 (7.0) 121 (8.3) 502 (15.2) 0 (0.0) 
≥ 3 231 (2.6) 56 (3.9) 175 (5.3) 0 (0.0) 
Ultrasonography 
performed 
8539 (96.0)*     
Ultrasound findings      
Thick-walled 2855 (32.8)† 729 (51.9) 1412 (43.6) 714 (17.6) < 0.001 
CBD dilated 1398 (16.0)‡ 289 (20.6) 793 (24.5) 316 (7.8) < 0.001 
CT performed 1307 (14.8)§ 290 (20.1) 680 (20.8) 337 (8.2) < 0.001 
MRCP performed 2301 (26.1)¶ 417 (28.9) 1319 (40.2) 565 (13.8) < 0.001 
 27 
ERCP performed 960 (10.9) 139 (9.6) 670 (20.5) 151 (3.7) < 0.001 
Values in parentheses are percentages. CBD common bile duct; MRCP magnetic retrograde 
cholangiopancreatography; ERCP endoscopic retrograde cholangiopancreatography. Data 
missing for *12, †219, ‡212, §101, ¶93 and 105 patients. **2 test or Fisher’s exact test, as 
appropriate. 
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Table 2 Surgical and hospital-related factors in 8909 cholecystectomies according to 
performance of emergency, delayed or elective cholecystectomy 
 All 
patients 
(n = 8909) 
Emergency 
cholecystectomy 
(n = 1451) 
Delayed 
cholecystectomy 
(n = 3293) 
Elective 
cholecystectomy 
(n = 4165) P‡ 
Grade of operating surgeon      
Junior trainee 403 (4.5) 91 (6.3) 114 (3.5) 198 (4.8) < 0.001 
Senior trainee 1488 
(16.7) 
278 (19.2) 503 (15.3) 707 (17.0) < 0.001 
Consultant 7007 
(78.7) 
1080 (74.5) 2675 (81.3) 3252 (78.2) < 0.001 
    Missing 11 2 1 8  
Consultant present 7755 
(89.5)* 
1178 (85.9) 2940 (90.9) 3637 (89.6) < 0.001 
Consultant specialty     < 0.001 
Oesophagogastric 3416 
(38.5) 
560 (38.8) 1220 (37.1) 1636 (39.5)  
HPB 1918 
(21.6) 
314 (21.8) 634 (19.3) 970 (23.4) 
Colorectal 1958 
(22.1) 
352 (24.4) 831 (25.3) 775 (18.7) 
Breast 348 (3.9) 42 (2.9) 137 (4.1) 169 (4.1) 
Vascular 373 (4.2) 57 (3.9) 141 (4.3) 175 (4.2) 
Other 863 (9.7) 117 (8.1) 327 (9.9) 419 (10.1) 
Missing  33 9 3 21  
Operative method     < 0.001 
Laparoscopic 8523 
(95.7) 
1343 (92.6) 3105 (94.3) 4075 (97.8)  
Converted 297 (3.3) 77 (5.3) 152 (4.6) 68 (1.6) 
Open 89 (1.0) 31 (2.1) 36 (1.1) 22 (0.5) 
Hospital type     < 0.001 
Non-university 4843 
(54.4) 
687 (47.3) 1915 (58.2) 2241 (53.8)  
University 4066 
(45.6) 
764 (52.7) 1378 (41.8) 1924 (46.2) 
Tertiary HPB centre     < 0.001 
No 6602 
(74.1) 
941 (64.9) 2588 (78.6) 3073 (73.8)  
Yes 2307 
(25.9) 
510 (35.1) 705 (21.4) 1092 (26.2) 
Acute hospital     < 0.001 
No 561 96.3) 13 (0.9) 222 (6.7) 326 (7.8)  
Yes 8348 
(93.7) 
1438 (99.1) 3071 (93.3) 3839 (92.2) 
Day case     < 0.001 
   No 1297 
(97.1) 
1297 (97.1) 958 (29.2) 822 (19.8)  
 29 
   Yes 39 (2.9) 39 (2.9) 2324 (70.8) 3337 (80.2) 
   Missing 132 115 11 6  
Emergency cholcystectomy 
list 
    < 0.001 
No 6036 67.8) 993 (68.4) 2225 (67.6) 2818 (67.7)  
Ad hoc 984 (11.0) 152 (10.5) 403 (12.2) 429 (10.3) 
Once per week 646 (7.3) 162 (11.2) 212 (6.4) 272 (6.5) 
More than once per week 788 (8.8) 138 (9.5) 292 (8.9) 358 (8.6) 
Elective surgery only at 
    hospital 
455 (5.1)) 6 (0.4) 161 (4.9) 288 (6.9) 
Nassar operative difficulty 
score 
    < 0.001 
1 3554 
(40.2) 
360 (25.1) 1146 (35.1) 2048 (49.5)  
2 2644 
(29.9) 
374 (26.1) 942 (28.9) 1328 (32.1) 
3 1814 
(20.5) 
423 (29.5) 775 (23.8) 616 (14.9) 
4 821 (9.3) 278 (19.4) 397 (12.2) 146 (3.5) 
    Missing 76 16 33 27  
IOC     < 0.001 
Not performed 7770 
(87.9) 
1121 (78.0) 2869 (87.6) 3780 (91.6)  
Planned 965 (10.9) 295 (20.5) 354 (10.8) 316 (7.7) 
Unplanned 105 (1.2) 22 (1.5) 54 (1.6) 29 (0.7) 
    Missing 69 13 16 40  
CBD exploration 282† 99 (6.9) 113 (3.4) 70 (1.7) < 0.001 
Values in parentheses are percentages. HPB hepatobiliary; IOC, intraoperative 
cholangiography; CBD, common bile duct. Data missing for *244 and †75 patients. ‡2 test. 
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Table 3 Thirty-day readmission and complications according to performance of emergency 
delayed or elective cholecystectomy.  
 
 
 
Emergency 
cholecystectomy 
(n = 1451) 
Delayed 
cholecystectomy 
(n = 3293) 
Elective 
cholecystectomy 
(n = 4165) P‡ 
Readmissions  138 (9.5) 270 (8.2) 225 (5.4) < 0.001 
All complications 223 (15.4) 420 (12.8) 319 (7.7) < 0.001 
Intraoperative 
complications 
    
Stones spilt 222 (15.3) 400 (12.1) 224 (5.4) < 0.001 
Bleeding 195 (13.4) 302 (9.2) 257 (6.2) < 0.001 
Bowel injury 8 (0.6) 22 (0.7) 19 (0.5) 0.479 
CBD injury 5 (0.3) 12 (0.4) 7 (0.2) 0.232 
Postoperative 
complications 
    
Collections 44 (3.0) 88 (2.7) 57 (1.4) < 0.001 
Surgical-site infection  38 (2.6) 78 (2.4) 76 (1.8) 0.114 
Pancreatitis  13 (0.9) 19 (0.6) 4 (0.1) < 0.001 
CBD stone  30 (2.1) 28 (0.9) 25 (0.6) < 0.001 
Bile leak  32 (2.2) 52 (1.6) 37 (0.9) < 0.001 
Respiratory  29 (2.0) 69 (2.1) 29 (0.7) < 0.001 
Reimaging  172 (11.8) 300 (9.1) 206 (4.9) < 0.001 
Radiological drain  16 (1.1) 37 (1.1) 16 (0.4) < 0.001 
Relaparoscopy  
or laparotomy 
7 (0.5) 27 (0.8) 27 (0.6) 0.399 
30-day mortality 3 (0.2) 6 (0.2) 2 (0.05) 0.160 
Values in parentheses are percentages. CBD, common bile duct. *2 test. 
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Table 4 Multilevel random intercept logistic regression analysis of association between 
patient and surgery characteristics with all-cause 30-day readmission following 
cholecystectomy  
 
 Odds ratio  P 
Random intercept 0.07 (0.06, 0.09) < 0.001 
Patient factors   
Age (years)                                                         
   < 40 1.00 (reference)  
   40–60 0.78 (0.63, 0.95) 0.014 
   61–80 0.72 (0.58, 0.91) 0.005 
   > 80 0.56 (0.33, 0.94) 0.028 
ASA fitness grade                      
I–II 1.00 (reference)  
II–IV 1.47 (1.14, 1.90) 0.003 
Surgical factors   
Surgery admission type   
Delayed 1.00 (reference)  
Emergency 0.91 (0.68, 1.21) 0.519 
Elective 0.48 (0.35, 0.66) < 0.001 
No. of surgical admissions   
0 1.00 (reference)  
1 1.50 (1.11, 2.03) 0.009 
≥ 2 1.59 (1.18, 2.14) 0.002 
Duration of surgery (per min) 1.01 (1.00, 1.01) 0.043 
Values in parentheses are 95 per cent confidence intervals.  
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Table 5 Multilevel random intercept logistic regression of the association between patient 
and surgery characteristics with all-cause 30-day complications following cholecystectomy  
 Odds ratio  P 
Random intercept 0.06 (0.04, 0.07) < 0.001 
Patient factors   
Age (years)                                                         
< 40 1.00 (reference)  
40–60 0.78 (0.65, 0.95) 0.012 
60–80 0.98 (0.80, 1.19) 0.838 
> 80 1.52 (1.08, 2.16) 0.018 
ASA fitness grade                      
I–II 1.00 (reference)  
II–IV 1.44 (1.17, 1.78) 0.001 
Surgical factors   
Surgical admission type   
Delayed 1.00 (reference)  
Emergency 1.01 (0.80, 1.29) 0.902 
Elective 0.61 (0.46, 0.81) < 0.001 
No. of surgical admissions   
0 1.00 (reference)  
1 1.36 (1.05, 1.75) 0.021 
≥ 2 1.28 (0.99, 1.65) 0.055 
Method of operation   
Laparoscopic 1.00 (reference)  
Open 1.77 (1.04, 3.01) 0.034 
Laparoscopic converted to open 2.59 (1.91, 3.52) < 0.001 
Duration of surgery (per min) 1.01 (1.01, 1.01) 0.003 
Level of operation difficulty (per Nassar level) 1.22 (1.12, 1.33) < 0.001 
Values in parentheses are 95 per cent confidence intervals.  
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